XML 27 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (76.0) $ (1.2)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Loss on sale of BHH 4.3 0.0
Unrealized (gain) loss on derivative instruments (10.9) (1.9)
Lower of cost or NRV inventory adjustment 15.8 5.9
Depreciation and amortization 63.0 67.5
Helguvik (gains) 0.0 (4.5)
Other non-cash items - net (5.9) (4.0)
Change in operating assets and liabilities:    
Accounts receivable - net 10.7 (48.3)
Due from affiliates (0.2) (10.1)
Inventories 5.7 (78.8)
Prepaid and other current assets 3.8 1.8
Accounts payable, trade (11.3) 23.4
Due to affiliates (10.3) (3.8)
Accrued and other current liabilities 8.4 1.7
Ravenswood retiree medical settlement (2.0) (2.0)
Other - net 0.5 (4.7)
Net cash provided by (used in) operating activities (4.4) (59.0)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property, plant and equipment (39.9) (49.3)
Proceeds from sale of joint venture 10.5 0.0
Net cash provided by (used in) investing activities (29.4) (49.3)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings under term loan 40.0 0.0
Borrowings under revolving credit facilities 314.6 14.3
Repayments under revolving credit facilities (337.5) 0.0
Other short-term borrowings 3.4 0.0
Repayment on other short-term borrowings (3.4) 0.0
Issuance of common stock 0.3 0.2
Net cash provided by (used in) financing activities 17.4 14.5
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (16.4) (93.8)
Cash, cash equivalents and restricted cash, beginning of period 39.7 168.0
Cash, cash equivalents and restricted cash, end of period 23.3 74.2
Cash paid for:    
Interest 11.6 9.9
Taxes 0.3 4.6
Non-cash investing activities:    
Capital expenditures $ 3.9 $ 6.5